ClinicalTrials.govpublic full text
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
non alcoholic fatty liver disease, type2 diabetes mellitus, type 2 diabetes mellitus, glp-1 receptor agonist, dulaglutide, mri-proton density fat fraction, fat mapping, non alcoholic steatohepatitis, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807168
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.